A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The story of HCPs’ advocacy for the Treat and Reduce Obesity Act reveals a broader truth: HCPs care deeply about the ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Use of anti-obesity medications or AOMs and the associated demand for protein rich foods is a global trend set to benefit ...